Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women.

NCT04270773 is registered in ClinicalTrials.gov with University Hospital Virgen de las Nieves as lead sponsor.

NCT NCT04270773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04270773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women.
Lead sponsor
University Hospital Virgen de las Nieves
Phase
Phase 4
Overall status
Unknown status
Start date
February 12, 2020
Completion date
December 30, 2024
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hpv infection